There is preliminary evidence that colchicine, an inhibitor of collagen synthesis, may be
beneficial in the treatment of cirrhosis of the liver. To evaluate the use of colchicine (1 mg per day…

Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Two genome-wide association studies (GWAS) have described associations of variants in
PNPLA3 with nonalcoholic fatty liver and plasma liver enzyme levels. We investigated the …

Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…

The topic of free radicals and antioxidants is widely dis—cussed, not only in the biologic and
medical literature but also in reading for the general public. Advertisements urge you to “…

Mexico is reaching universal health coverage in 2012. A national health insurance
programme called Seguro Popular, introduced in 2003, is providing access to a package of …

Background and aim: The purpose of the present investigation is to provide an analysis of
previous works on the epidemiology of the hepatitis C virus (HCV) infection from six countries …

Background/Aims: Autoimmune hepatitis has a genetic background associated with different
HLA DRB1 alleles depending on the ethnic group. The aim of this study was to analyse the …

Five different target mitochondrial autoantigens recognized by sera from patients with
primary biliary cirrhosis (PBC) have been identified as subunits of the following 2‐oxo acid …

Introduction Chronic hepatitis C (CHC) is considered an important public health challenge.
Traditionally identified risk factors have undergone an epidemiological transition where other …